NCT06465862View on ClinicalTrials.gov

Development of a Silica Microparticle Taggant System to Measure ART Adherence

NANot yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 15, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

April 15, 2025

Conditions
HivMedication AdherenceCompliance, Medication
Interventions
DEVICE

TruTag System

TruTag technology system, consisting of microparticle-tagged Biktarvy and companion smartphone app.

DRUG

Biktarvy Pill

Biktarvy prescribed with TruTag system and tagged with TruTag microparticles.

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

collaborator

Trutag Technologies

UNKNOWN

collaborator

Gilead Sciences

INDUSTRY